富士康於鄭州成立新事業總部
富士康新事業總部揭牌儀式今日(25日)在鄭州舉行。自2010年富士康入駐鄭州以來,雙方不斷深化戰略合作,已將鄭州富士康打造成為富士康全球最大的智能終端生產基地。
富士康新事業總部作為雙方戰略合作的核心內容,主要聚焦新興產業轉化落地,制定發展規劃、開展核心技術研究、進行產業投資統籌管理、實施產業項目孵化和落地等。河南將全力支持富士康以及產業鏈供應鏈創新鏈上下游合作夥伴到河南投資興業。
富士康董事長劉揚偉表示,集團將繼續與地方政府、行業夥伴,以及廣大員工攜手並進,全力以赴面向戰略產業在河南再造一個「新的富士康」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.